References
- Goldstein ST, Fiore AE. Toward the global elimination of hepatitis B virus transmission. J. Pediatr.139(3), 343–345 (2001).
- WHO. Hepatitis B vaccines: WHO position paper – recommendations. Vaccine28(3), 589–590 (2010).
- Plotkin S, Orenstein WA, Offit PA. Hepatitis B. In: Vaccines (Fifth Edition). Saunders Elsevier, Philadelphia, PA, USA (2008).
- Lee C, Gong Y, Brok J et al. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst. Rev.2, CD004790 (2006).
- Lee C, Gong Y, Brok J et al. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ332(7537), 328–336 (2006).
- Isaacs D, Kilham H, Alexander S et al. Ethical issues in preventing mother-to-child transmission of hepatitis B by immunisation. Vaccine29(37), 6159–6162 (2011).
- Ip H, Lelie P, Wong V et al. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet1(8635), 406–410 (1989).
- Xu ZY, Duan SC, Margoliis HS et al. Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States–People’s Republic of China Study Group on Hepatitis B. J. Infect. Dis.171(1), 54–60 (1995).
- Mast E, Margolis H, Fiore A et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Morb. Mortal. Wkly Rep.54 RR(16), 1–23 (2005).
- Mast E, Weinbaum C, Fiore A et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP) part 2: immunization of adults MMWR Morb. Mortal. Wkly Rep.55 RR(16), 1–25 (2006).
- Gambarin-Gelwan M. Hepatitis B in pregnancy. Clin. Liver Dis.11(4), 945–963 (2007).
- Xu D, Yan Y, Choi B et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case control study. J. Med. Virol.67(1), 20–26 (2002).
- Levy M, Koren G. Hepatitis B in pregnancy: maternal and fetal safety. Am. J. Perinatol.8(3), 227–232 (1991).
- Ngui S, Andrews N, Underhill G, Heptonstall J, Teo C. Failed postnatal prophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin. Infect. Dis.27(1), 100–106 (1998).
- Degli Esposti S, Shah D. Hepatitis B in pregnancy: challenges and treatment. Gastro Clin. Nth. Am.40(2), 355–372 (2011).
- Sangkomkamhang US, Lumbiganon P, Laopaiboon M. Hepatitis B vaccination during pregnancy for preventing infant infection. Cochrane Database Syst. Rev.3, CD007879 (2011).
- Shi Z, Li X Ma L, Yang Y. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother to child transmission – a meta analysis. Int. J. Infect. Dis.14(7), e622–e634 (2010).
- Yuan J, Lin J, Xu A et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomised study. J. Med. Virol.13(9), 597–604 (2006).
- Yu M, Ji Y, Jiang H, Ju L, Wu K, Kan N. Efficacy of peripartum antiviral treatment for hepatic failure due to hepatitis B virus. Int. J. Gynaecol. Obstet.114(1), 33–36 (2011).
- Shi Z, Yang Y, Ma L, Li X, Schreiber A. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol.116(1), 147–159 (2010).